Table 1.
Clinical and pathological characteristics of the study cohort
| Characteristic | All patients (n=48) | Early stage (n = 35) |
Late stage (n=13) |
|---|---|---|---|
| Age in years, mean (s.d.) | 58.0 (12.0) | 58.3 (11.7) | 58.1 (13.9) |
| Endometrioid grade, n (%) | |||
| 1 | 0 (0%) | 0 (0%) | 0 (0%) |
| 2 | 30 (62%) | 24 (69%) | 6 (46%) |
| 3 | 18 (38%) | 11 (31%) | 7 (54%) |
| aMyometrial invasion, n (%) | |||
| <50% | 30 (64%) | 27 (77%) | 3 (25%) |
| ≥ 50% | 17 (36%) | 8 (23%) | 9 (75%) |
| bLVSI, N (%) | |||
| No | 25 (53%) | 24 (69%) | 1 (8%) |
| Yes | 22 (47%) | 11 (31%) | 11(92%) |
| cTumor size in cm, mean (s.d.) | 5.3 (3.4) | 5.1 (3.7) | 5.8 (2.7) |
| DNA mismatch repair | |||
| Intact | 30 (63%) | 24 (69%) | 6 (46%) |
| Deficient | 18 (37%) | 11 (31%) | 7 (54%) |
a
Data missing for one patient.
b
LVSI, lymphatic/vascular space invasion; data missing for one patient.
c
Data missing for two patients